Skip to main content
OpenTrials
Completed

NCT Number: NCT00965640

Treatment of Male Pattern Baldness With Botulinum Toxin

This proof of concept study seeks to demonstrate that Botulinum toxin injections are a safe and effective method for treating this form of hair loss.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Male Pattern Baldness Alopecia Hair Diseases Hypotrichosis Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–65 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 2

Primary location

Crown Institute

Pickering, Ontario, L1V 1B1, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male pattern baldness
  • Norwood II-VI

Exclusion criteria

  • Treatment with Botulinum toxins or other hair growth interventions with past year

Treatment and study plan

Botulinum Toxin - A injections

Drug

Primary outcomes

  1. Hair Growth

    Time frame: 1 year

Secondary outcomes

  1. Hair Loss

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

The Crown Institute

Other

Registry information

Official study title

A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia

Important dates

Study start
2002
Primary completion
2004
Study completion
2004
First posted
Aug 25, 2009
Registry last updated
Aug 25, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.